Ascendis Pharma A
corporate_fare Company Profile
Ascendis Pharma A (NASDAQ:ASND) is a publicly traded company in the Life Sciences sector. Wiseek monitors ASND SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Ascendis Pharma Reports Strong 2025 Financials, Driven by YORVIPATH Sales & Pipeline Progress; Announces $120M Share Repurchase
- Ascendis Pharma Unveils Strong Pipeline Progress & $120M Share Repurchase
- Ascendis Pharma Reports Strong Phase 2 Results for Achondroplasia Combination Therapy
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
€720.13M EUR
Net Income
-€228.03M EUR
Diluted EPS
-€3.76 EUR
Op. Cash Flow
€53.9M EUR
Gross Profit
€625.22M EUR
Operating Income
-€136.27M EUR
Cash & Equivalents
€616.04M EUR
Total Debt
€385.25M EUR
Debt / Equity
-2.37×
Net Margin
-31.7%
Shares Outstanding
61.98M sh
Source: 20-F · filed 2026-02-11 · accession 0001193125-26-046590
Insider Transactions
ASND files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed ASND - Filings & News (Page 2)
ASND
Feb 11, 2026, 4:15 PM EST
Price at Filing:
$216.23
Real-time Price:
$218.06
Change:
+$1.83 (+0.84%)
Market Cap:
$13.602B
ASND
Jan 12, 2026, 6:04 AM EST
Price at Filing:
$207.00
Real-time Price:
$218.06
Change:
+$11.06 (+5%)
Market Cap:
$13.602B
ASND
Jan 08, 2026, 6:26 PM EST
Price at Filing:
$208.75
Real-time Price:
$218.06
Change:
+$9.31 (+4%)
Market Cap:
$13.602B